Bio-Rad Labs (BIO) Tops Q3 EPS by $1.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Bio-Rad Labs (BIO) Tops Q3 EPS by $1.20
October 29, 2020 4:15 PM EDT
HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2020.
Third-quarter 2020 net sales were $647.3 million, an increase of 15.5 percent compared to $560.6 million reported for the third quarter of 2019. On a currency-neutral basis, quarterly sales increased 14.9 percent compared to the same period in 2019. Third-quarter gross margin was 56.7 percent compared to 54.8 percent during the third quarter in 2019.
Life Science segment net sales for the third quarter were $324.0 million, an increase of 50.2 percent compared to the... More
